Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?

Title
Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 15, Issue 3, Pages 351-353
Publisher
Informa Healthcare
Online
2011-01-06
DOI
10.1517/14728222.2011.550880

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now